Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion

In this era of immune checkpoint inhibitors, inflammatory adverse events of anti-cancer therapies continue to pose a major challenge. Glucocorticoids, as the mainstay, were limited by serious side effects. Glucocorticoids induce myeloid-derived suppressor cells (MDSCs), and lactoferrin-induced polym...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xing, Chen, Jie, Chen, Yong-Jian, Qiao, Yi-Dan, Zhao, Li-Yun, Jiang, Nan, Wu, Xiang-Yuan, Xing, Yan-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910613/
https://www.ncbi.nlm.nih.gov/pubmed/33637832
http://dx.doi.org/10.1038/s42003-021-01769-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910613/
https://www.ncbi.nlm.nih.gov/pubmed/33637832
http://dx.doi.org/10.1038/s42003-021-01769-z

Ejemplares similares